The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 43 | — | 20.1x | Near average | |
Growth | 89 | 1205.5% | 5.6% | Above average | |
Quality | 40 | -47.7% | 7.6% | Near average | |
Safety | 35 | 0.7x | 0.4x | Near average | |
Capital Return | 26 | — | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Nuvation Bio Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Nuvation Bio Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Nuvation Bio stock shows remarkable stability in the average price target at 13 dollars over the past thirty days, with a significant price gap between the low (10 dollars) and the high (17 dollars), reflecting a variance in fair value estimation despite the consensus of the three current analysts on a positive outlook compared to the current market price. The stock is trading at a significant discount to the target price, indicating analyst optimism regarding future growth potential.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.